The altered metabolic pathways of diffuse large B-cell lymphoma not otherwise specified

被引:0
|
作者
Rodrigues-Fernandes, Carla Isabelly [1 ]
Martins-Chaves, Roberta Rayra [2 ]
Vitorio, Jessica Gardone [2 ]
Duarte-Andrade, Filipe Fideles [2 ]
Pereira, Thais dos Santos Fontes [2 ]
Soares, Ciro Dantas [3 ]
Moreira, Victor Rezende [4 ]
Lebron, Yuri Abner Rocha [4 ]
Santos, Lucilaine Valeria de Souza [4 ]
Lange, Lisete Celina [4 ]
Canuto, Gisele Andre Baptista [5 ]
Gomes, Carolina Cavalieri [6 ]
de Macedo, Adriana Nori [7 ]
Pontes, Helder Antonio Rebelo [8 ]
Burbano, Rommel Mario Rodriguez [8 ]
Martins, Manoela Domingues [9 ]
Pires, Fabio Ramoa [10 ]
Mesquita, Ricardo Alves [2 ]
Gomez, Ricardo Santiago [2 ]
Santos-Silva, Alan Roger [1 ]
Lopes, Marcio Ajudarte [1 ]
Vargas, Pablo Agustin [1 ]
Fonseca, Felipe Paiva [2 ]
机构
[1] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Oral Diag Semiol & Pathol Areas, UNICAMP, Piracicaba, SP, Brazil
[2] Univ Fed Minas Gerais UFMG, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, Brazil
[3] Getulio Sales Lab, Natal, RN, Brazil
[4] Univ Fed Minas Gerais UFMG, Sch Engn, Dept Sanitat & Environm Engn, Belo Horizonte, Brazil
[5] Univ Fed Bahia UFBA, Inst Chem, Dept Analyt Chem, Salvador, Brazil
[6] Univ Fed Minas Gerais UFMG, Biol Sci Inst, Dept Pathol, Belo Horizonte, Brazil
[7] Univ Fed Minas Gerais UFMG, Exact Sci Inst, Dept Chem, Belo Horizonte, Brazil
[8] Fed Univ Para UFPA, Joao de Barros Barreto Univ Hosp, Serv Oral Pathol, Belem, Brazil
[9] Fed Univ Rio Grande Sul UFRGS, Sch Dent, Dept Pathol, Porto Alegre, Brazil
[10] Rio de Janeiro State Univ UERJ, Dent Sch, Oral Pathol, Rio De Janeiro, Brazil
关键词
Non-Hodgkin l-ymphoma; diffuse large B-cell lymphoma; metabolomics; metabolic pathways; GENE-EXPRESSION; VITAMIN-E; NATURAL FORMS; CLASSIFICATION; ANTIOXIDANT; TISSUE; ALPHA; ACTIVATION; PREVENTION; ORIGIN;
D O I
10.1080/10428194.2023.2234523
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Altered metabolic fingerprints of Diffuse large B-cell lymphoma, not otherwise specified (DLBCL NOS) may offer novel opportunities to identify new biomarkers and improve the understanding of its pathogenesis. This study aimed to investigate the modified metabolic pathways in extranodal, germinal center B-cell (GCB) and non-GCB DLBCL NOS from the head and neck. Formalin-fixed paraffin-embedded (FFPE) tissues from eleven DLBCL NOS classified according to Hans' algorithm using immunohistochemistry, and five normal lymphoid tissues (LT) were analyzed by high-performance liquid chromatography-mass spectrometry-based untargeted metabolomics. Partial Least Squares Discriminant Analysis showed that GCB and non-GCB DLBCL NOS have a distinct metabolomics profile, being the former more similar to normal lymphoid tissues. Metabolite pathway enrichment analysis indicated the following altered pathways: arachidonic acid, tyrosine, xenobiotics, vitamin E metabolism, and vitamin A. Our findings support that GCB and non-GCB DLBCL NOS has a distinct metabolomic profile, in which GCB possibly shares more metabolic similarities with LT than non-GCB DLBCL NOS.
引用
收藏
页码:1771 / 1781
页数:11
相关论文
共 50 条
  • [21] CD30 Expression in Oral and Oropharyngeal Diffuse Large B Cell Lymphoma, not Otherwise Specified
    Morais-Perdigao, Ana Luisa
    Rodrigues-Fernandes, Carla Isabelly
    Araujo, Gabriela Ribeiro
    Soares, Ciro Dantas
    Benevenuto de Andrade, Bruno Augusto
    Martins, Manoela Domingues
    Vargas, Pablo Agustin
    Rebelo Pontes, Helder Antonio
    Pires, Fabio Ramoa
    Rodriguez Burbano, Rommel Mario
    Fonseca, Felipe Paiva
    HEAD & NECK PATHOLOGY, 2022, 16 (02): : 476 - 485
  • [22] Diffuse Large B-Cell Lymphoma
    Sehn, Laurie H.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 842 - 858
  • [23] Diffuse large B-cell lymphoma
    Fuchs, David
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (01) : 7 - 11
  • [24] Diffuse large B-cell lymphoma
    Martelli, Maurizio
    Ferreri, Andres J. M.
    Agostinelli, Claudio
    Di Rocco, Alice
    Pfreundschuh, Michael
    Pileri, Stefano A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (02) : 146 - 171
  • [25] An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified
    Hoffmann, Jenny C.
    Chisholm, Karen M.
    Cherry, Athena
    Chen, Jennifer
    Arber, Daniel A.
    Natkunam, Yasodha
    Warnke, Roger A.
    Ohgami, Robert S.
    HUMAN PATHOLOGY, 2016, 48 : 9 - 17
  • [26] EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management
    Beltran, Brady E.
    Castro, Denisse
    Paredes, Sally
    Miranda, Roberto N.
    Castillo, Jorge J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (04) : 435 - 445
  • [27] CD43 expression in diffuse large B-cell lymphoma, not otherwise specified: CD43 is a marker of adverse prognosis
    Ma, Xiao-Bo
    Zheng, Yan
    Yuan, He-pei
    Jiang, Jing
    Wang, Yin-Ping
    HUMAN PATHOLOGY, 2015, 46 (04) : 593 - 599
  • [28] EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management
    Castillo, Jorge J.
    Beltran, Brady E.
    Miranda, Roberto N.
    Young, Ken H.
    Chavez, Julio C.
    Sotomayor, Eduardo M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 953 - 962
  • [29] EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management
    Malpica, Luis
    Marques-Piubelli, Mario L.
    Beltran, Brady E.
    Chavez, Julio C.
    Miranda, Roberto N.
    Castillo, Jorge J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (10) : 2002 - 2015
  • [30] Prognostic Significance of BAD and AIF Apoptotic Pathways in Diffuse Large B-Cell Lymphoma
    Troutaud, Danielle
    Petit, Barbara
    Bellanger, Cynthia
    Marin, Benoit
    Gourin-Chaury, Marie-Pierre
    Petit, Daniel
    Olivrie, Agnes
    Feuillard, Jean
    Jauberteau, Marie-Odile
    Bordessoule, Dominique
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (02): : 118 - 124